Xbrane Biopharma AB (publ), a biotechnology company, develops, manufactures, and sells biosimilars. The company is developing Xlucane, a ranibizumab biosimilar that is in Phase III clinical trials used for the treatment of wet age-related macular degeneration, diabetic macular edema, diabetic related retinopathy, and retinal vein occlusion. Its pre-clinical phase products include Xcimzane for rheumatoid arthritis, axial spondylarthrosis, psoriatic arthritis, and psoriasis and crohn diseases; Xoncane for acute lymphocytic leukemia; Spherotide for prostate cancer, breast cancer, endometriosis, and myoma; and Xdivane for melanoma, lung, head and throat, bladder, and urinary tract cancer, as well as for renal cell carcinoma. The company has a strategic biosimilar development partnership with STADA Arzneimittel AG to evaluate development and commercialization collaborations around its Xcimzane and Xdivane preclinical biosimilars. Xbrane Biopharma AB (publ) was founded in 2008 and is headquartered in Solna, Sweden. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Xbrane Biopharma.
Xbrane Biopharma business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Xbrane Biopharma are also analyzed.
Detailed
SWOT Analysis of the company including key strengths and weaknesses of Xbrane Biopharma , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Xbrane Biopharma including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Xbrane Biopharma and all latest updates of the company are provided.
The 2025 version of Xbrane Biopharma report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Xbrane Biopharma- Key Facts
2.2 Xbrane Biopharma- Geographic Locations
2.3 Xbrane Biopharma- Subsidiaries and Affiliates
2.4 Xbrane Biopharma- Business Divisions
2.5 Xbrane Biopharma- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Xbrane Biopharma Strategic Analysis Review
3.1 Xbrane Biopharma- Key Strategies
3.2 Xbrane Biopharma- Company Outlook Statement
3.3 Xbrane Biopharma- SWOT Analysis
3.3.1 Xbrane Biopharma- Key Strengths
3.3.2 Xbrane Biopharma- Key Weaknesses
3.3.3 Xbrane Biopharma- Potential Opportunities
3.3.4 Xbrane Biopharma- Potential Threats
3.4 Xbrane Biopharma- Key Competitors
4. Business Description of the Company
4.1 Xbrane Biopharma- Business Overview
4.2 Xbrane Biopharma- Operations by Segment
5 Products and Services Details
5.1 Xbrane Biopharma- Key Products
5.2 Xbrane Biopharma- Key Service Areas
5.3 Xbrane Biopharma- Key Brands
6 Company Developments
6.1 Xbrane Biopharma- Company History
6.2 Xbrane Biopharma- Latest Developments
7 Financial Analysis
7.1 Xbrane Biopharma- Income Statements
7.2 Xbrane Biopharma- Balance Sheet
7.3 Xbrane Biopharma- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Xbrane Biopharma- Direct Competitors
8.2 Xbrane Biopharma- Competitor Financial Ratios comparison
8.3 Xbrane Biopharma- Competitor Stock Charts Comparison
8.4 Xbrane Biopharma- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!